Evidence map›Paper›PMID 36147600›Full record

ArticleOpen forum infectious diseases2022

From Start to Finish: Examining Factors Associated With Higher Likelihood of Publication Among Abstracts Presented at an International Infectious Diseases Scientific Meeting.

Asia J Johnson, Christopher M Bland, Chengwen Teng, Lily Zheng, J Colin Hungerpiller, Morgan Easterling, Sarah Arnold, Madeline Dean, Carrington Royals, P Brandon Bookstaver

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Asia J JohnsonDepartment of Pharmacy, Baylor University Medical Center, Dallas, Texas, USA.
Christopher M BlandDepartment of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Savannah, Georgia, USA.ORCID https://orcid.org/0000-0001-8806-4583
Chengwen TengDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.ORCID https://orcid.org/0000-0001-9239-2125
Lily ZhengDepartment of Pharmacy, University of Florida Health Shands Hospital, Gainesville, Florida, USA.
J Colin HungerpillerDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.
Morgan EasterlingDepartment of Pharmacy, Le Bonheur Children's Hospital and University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Sarah ArnoldDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.
Madeline DeanDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.
Carrington RoyalsDepartment of Pharmacy, Tandem Health SC, Inc, Sumter, South Carolina, USA.
P Brandon BookstaverDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.ORCID https://orcid.org/0000-0002-4409-0963

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The landscape of infectious diseases research by interprofessional teams continues to change in both scope and engagement. Limited information exists regarding publication metrics and factors associated with publication of abstracts presented at professional infectious diseases meetings. Methods: This was a retrospective, observational study evaluating abstracts presented at IDWeek in 2017 and 2018. The primary endpoint was the proportion of abstracts that were subsequently published in peer-reviewed journals. Factors associated with publication were evaluated, and a description of publication metrics was reported. Results: Of the 887 abstracts analyzed from the IDWeek meetings, 236 (26.6%) were published. Significantly more abstracts were published if they were presented as a platform presentation versus poster presentation (35% vs 21%, Conclusions: Abstracts from IDWeek presented as oral platforms and those including a PhD author were more likely to be published. Large, diverse authorship teams were common among published abstracts. The high quality of resulting manuscripts is evident by the destination journals and their respective impact factors. These data may be used to inform and motivate clinicians and trainees engaging in infectious diseases-related research.

Indexed as

abstractsacademicianIDSAIDWeekpublicationsresearch

Identifiers

PMID36147600
PMCPMC9487641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.